Sundhedspersonale

Vi arbejder for at hjælpe dig med at håndtere både udfordringer og muligheder inden for patientplejen.

Sundhedspersonale

  • Vores innovative behandlinger og teknologier hjælper dig med at behandle intensivpatienter med livstruende tilstande og sygdomme.

  • Infusionsterapi og lægemiddeltilberedning

    Vi hjælper dig med at maksimere sikkerheden og udvikle omkostningseffektive processer på hele sygehuset, fra apoteket til sygesengen.

  • Ernæringsbehandling

    Akut og kronisk ernæringsbehandling til patienter, som ikke får tilstrækkelig næring oralt eller enteralt.

  • Nyrebehandling

    Vi er førende inden for løsninger til hæmodialyse og peritonealdialyse, så dine patienter kan få bedre resultater af behandlingen.

  • Kirurgi

    Vi tilbyder innovative kirurgiske produkter, som hjælper dig med trygt at kunne udføre operationer præcist og hurtigt.

  • Vores produkter

    Vores udbud af produkter til intensivbehandling, ernæring, dialyse, hospitalsbehandling og kirurgi forbedrer sundheds- og sygepleje over hele verden.

Perspektiv

I over 85 år har vi spillet en vigtig rolle i arbejdet med at redde og opretholde liv.

Perspektiv

Om os

Vores mere end 85 år lange erfaring har givet os omfattende perspektiver på, hvad patienter og sundhedspersonale har brug for. Vi er i dag førende i branchen, da vi har brugt vores viden til at udvikle nye og bedre sundheds- og behandlingsløsninger...

Om os
  • Virksomhedsledelse

    Vi er stolte over vores dedikerede fokus på at opretholde en høj standard når det gælder virksomhedsledelse.

  • Innovation gennem samarbejde

    ...Vi arbejder sammen med sundhedssektoren for hele tiden at finde mere effektive og intelligente måder at løse de mest akutte sundhedsproblemer i verden.

  • Virksomhedens ansvar

    Vi har fokus på at arbejde på den rigtige måde, støtte og udvikle vores medarbejdere, kunder, patienter og miljøet.

  • Inklusion og mangfoldighed

    For os er det vigtigt at kunne tiltrække, motivere og fastholde en inkluderende og mangfoldig personalestyrke.

  • Vores historie

    I over 85 år har vi arbejdet for at redde og opretholde liv og øge kvaliteten inden for patientbehandling.

Patienter

Vi hjælper dig med at leve et sundt liv, fuldt af muligheder.

Patienter
  • Intensivbehandling

    Når hvert sekund tæller, kan vores produkter og terapier hjælpe speciallægerne med at give dig eller én, som står dig nær, livsvigtig behandling.

  • Infusionsterapi og lægemiddeltilberedning

    Vores intravenøse lægemidler og infusionsteknologier, udviklet med fokus på sikkerhed, støtter dig og sundhedspersonalet hele vejen alt efter behov.

  • Ernæringsbehandling

    Hvis du lider af en sygdom, som gør, at du ikke får tilstrækkelig næring, kan vores livreddende ernæringsopløsninger hjælpe med at holde dig sund eller komme til kræfter igen.

  • Nyrebehandling

    Kronisk nyresygdom (CKD) – en varig rejse. Selvom sygdommen udvikles forskelligt fra person til person, er Baxter ved din side hele vejen med produkter, der passer ind i netop din hverdag.

  • Kirurgi

    Vi arbejder tæt sammen med operationsteams over hele verden, så de kan arbejde præcist og hurtigt og opnå vellykkede resultater.

Baxter Appoints Dr. David Wilkes to Its Board and Albert Stroucken as Lead Independent Director

Pressemeddelelse

  • Addition of Dr. Wilkes complements and expands current board expertise

  • Mr. Stroucken's appointment reflects ongoing board refreshment efforts

DEERFIELD, Ill. -

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced it has appointed David S. Wilkes, M.D., dean, University of Virginia School of Medicine, and co-founder and chief scientific officer of biotech start-up ImmuneWorks Inc., to its board of directors. Dr. Wilkes will serve on Baxter's Quality, Compliance and Technology Committee. Additionally, Baxter has appointed Albert P.L. Stroucken, former executive chairman and chief executive officer, Owens-Illinois, Inc., and a Baxter director since 2004, as its lead independent director. Mr. Stroucken, who previously served as the chairman of the Audit Committee, will succeed Thomas T. Stallkamp, who has served as lead independent director from May 2014 to February 2021. Mr. Stallkamp will continue to serve as a director of the board. Both new appointments are effective today and will bring the total number of directors serving the company to 13.    

“We are pleased to welcome Dr. Wilkes to Baxter's board,” said José (Joe) E. Almeida, chairman and chief executive officer. "His deep medical and research expertise, track record as a transformational leader, and distinguished career as an internationally recognized biotech entrepreneur will enhance and further diversify our current board membership. I'm confident his patient-centric approach and contributions will advance our Mission to save and sustain lives."

Added Mr. Almeida, "We extend our gratitude to Al for assuming the role as our new lead independent director. His experience as a former CEO and chair of Baxter's Audit Committee makes him uniquely suited to lead our board and provide management oversight. We also want to recognize Tom for his years of leadership and service as our lead independent director; his deep understanding of our business and the independence with which he has advanced this role have delivered tremendous value to Baxter and our stakeholders. We look forward to Tom's continued contributions to the board."

David S. Wilkes, M.D. 

Dr. Wilkes currently serves as dean of the University of Virginia School of Medicine, where he has led the medical school's transformation, which has included targeted initiatives to improve funding and research endeavors as well as diversity programs. He is also co-founder and chief scientific officer of ImmuneWorks Inc., a biotech company developing novel therapeutics for immune-mediated lung diseases; and the national director of the Harold Amos Medical Faculty Program for the Robert Wood Johnson Foundation, one of the nation’s leading programs in training physician scientists. Prior to these roles, Dr. Wilkes served in positions of increasing responsibility at Indiana University School of Medicine, where he focused on medical research. He received his bachelor's degree in biology from Villanova University, his medical degree from Temple University School of Medicine, and conducted his residency at Temple University Hospital. Dr. Wilkes completed a post-doctoral fellowship in pulmonary and critical care at University of Texas Southwestern Medical. He is also a military veteran, having served three years as a major in the U.S. Air Force Medical Corps. In 2020, Dr. Wilkes was elected to the prestigious National Academy of Medicine, one of the highest honors in the fields of health and medicine. 

Albert P.L. Stroucken

Mr. Stroucken is former executive chairman of the board of directors of Owens-Illinois, Inc., where he also served as chairman, president and chief executive officer. Mr. Stroucken previously served as chairman, president and chief executive officer of H.B. Fuller Company, a manufacturer of adhesives, sealants, coatings, paints and other specialty chemicals. Prior to these positions, he held roles of increasing responsibility at Bayer AG and Bayer Corporation. Mr. Stroucken previously served as a director of Baxalta Incorporated and as a director of Shire plc until its acquisition by Takeda Pharmaceutical Company Limited in January 2019.

About Baxter 

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.

Baxter is a registered trademark of Baxter International Inc.